Childhood AML clinical trials and research

Updated 11 Aug 2017

Although the outcome for children with blood cancer continues to improve, there's still a long way to go to improve treatments and quality of life for children affected by blood cancer.

Our researchers are making discoveries that will have a positive impact for children with AML.

> Find out more about Bloodwise’s research into childhood AML

Clinical trials for childhood acute myeloid leukaemia (AML)

If a clinical trial (study) becomes available while your child is being treated, your consultant may recommend you consider enrolling them in it.

Clinical trials are done for several reasons, including to look for new treatment options and to improve existing treatments. Taking part in a clinical trial has many advantages, such as the opportunity to have the newest available treatment which may not be offered outside the trial. Your child will also be very closely monitored and have detailed follow-up.

In a clinical trial, the best treatment available is compared with one that could be better – so your child will either have the current best available treatment, or the new one which could be better. Your child will still receive all the normal care that the NHS provides while they’re taking part in the trial.

Taking part in a clinical trial does come with uncertainties, so you may prefer that your child doesn’t take part. If you don’t want your child to be in a trial, or there isn’t a suitable trial available, they’ll be offered the best treatment available that’s suitable for their condition.

> Find out more about clinical trials

> Find out more about Bloodwise-funded trials for leukaemia

> Find clinical trials for childhood AML on the Cancer Research UK website

PIF memberStandard member